Skip to main content

Advertisement

SpringerLink
Log in

ASO Author Reflections: Nodal Downstaging and Conversion to Breast-Conserving Surgery Following Neoadjuvant Endocrine Therapy

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Spring LM, Gupta A, Reynolds KL, et al. Neoadjuvant endocrine therapy for estrogen receptor-positive breast cancer: a systematic review and meta-analysis. JAMA Oncol. 2016;2:1477–86.

    Article  Google Scholar 

  2. Petruolo OA, Pilewskie M, Patil S, et al. Standard pathologic features can be used to identify a subset of estrogen receptor-positive, HER2-negative patients likely to benefit from neoadjuvant chemotherapy. Ann Surg Oncol. 2017;24:2556–62.

    Article  Google Scholar 

  3. Montagna G, Sevilimedu V, Fornier M, et al. How effective is neoadjuvant endocrine therapy (NET) in downstaging the axilla and achieving breast-conserving surgery? Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-08888-7.

    Article  PubMed  Google Scholar 

  4. Iwata H, Masuda N, Yamamoto Y, et al. Validation of the 21-gene test as a predictor of clinical response to neoadjuvant hormonal therapy for ER+, HER2-negative breast cancer: the TransNEOS study. Breast Cancer Res Treat. 2019;173:123–33.

    Article  CAS  Google Scholar 

  5. Prat A, Saura C, Pascual T, et al. Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentre, randomised, phase 2 trial. Lancet Oncol. 2020;21:33–43.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA

    Giacomo Montagna MD, Monica Morrow MD & Melissa Pilewskie MD

Authors
  1. Giacomo Montagna MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Monica Morrow MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Melissa Pilewskie MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Melissa Pilewskie MD.

Ethics declarations

Disclosures

Dr. Monica Morrow has received speaking honoraria from Genomic Health. Dr. Giacomo Montagna was supported by the Ticino Cancer League, the Hanne Liebermann Foundation, the Fondation Ancrage, and the HEMMI-Stiftung. Dr. Melisssa Pilewskie has no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This ASO Author Reflections article offers a brief invited commentary on the article, “How Effective Is Neoadjuvant Endocrine Therapy (NET) in Downstaging the Axilla and Achieving Breast-Conserving Surgery?” Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-08888-7.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Montagna, G., Morrow, M. & Pilewskie, M. ASO Author Reflections: Nodal Downstaging and Conversion to Breast-Conserving Surgery Following Neoadjuvant Endocrine Therapy. Ann Surg Oncol 27 (Suppl 3), 693–694 (2020). https://doi.org/10.1245/s10434-020-08971-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-020-08971-z

Search

Navigation